IRON
Price
$45.73
Change
-$0.62 (-1.34%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
1.58B
86 days until earnings call
PHAT
Price
$3.25
Change
-$0.05 (-1.51%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
226.9M
85 days until earnings call
Ad is loading...

IRON vs PHAT

Header iconIRON vs PHAT Comparison
Open Charts IRON vs PHATBanner chart's image
Disc Medicine
Price$45.73
Change-$0.62 (-1.34%)
Volume$4.07K
Capitalization1.58B
Phathom Pharmaceuticals
Price$3.25
Change-$0.05 (-1.51%)
Volume$66.11K
Capitalization226.9M
IRON vs PHAT Comparison Chart
Loading...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRON vs. PHAT commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRON is a Hold and PHAT is a Hold.

Ad is loading...
COMPARISON
Comparison
May 15, 2025
Stock price -- (IRON: $46.35 vs. PHAT: $3.31)
Brand notoriety: IRON and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRON: 58% vs. PHAT: 65%
Market capitalization -- IRON: $1.58B vs. PHAT: $226.9M
IRON [@Biotechnology] is valued at $1.58B. PHAT’s [@Biotechnology] market capitalization is $226.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $289.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRON’s FA Score shows that 0 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • IRON’s FA Score: 0 green, 5 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, IRON is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRON’s TA Score shows that 4 TA indicator(s) are bullish while PHAT’s TA Score has 5 bullish TA indicator(s).

  • IRON’s TA Score: 4 bullish, 4 bearish.
  • PHAT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PHAT is a better buy in the short-term than IRON.

Price Growth

IRON (@Biotechnology) experienced а +8.87% price change this week, while PHAT (@Biotechnology) price change was +37.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.93%. For the same industry, the average monthly price growth was +6.80%, and the average quarterly price growth was -5.97%.

Reported Earning Dates

IRON is expected to report earnings on Aug 08, 2025.

PHAT is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+0.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($1.58B) has a higher market cap than PHAT($227M). IRON YTD gains are higher at: -26.893 vs. PHAT (-59.236). IRON has higher annual earnings (EBITDA): -114.41M vs. PHAT (-272.12M). IRON has more cash in the bank: 695M vs. PHAT (212M). IRON has less debt than PHAT: IRON (30.6M) vs PHAT (204M). PHAT has higher revenues than IRON: PHAT (81.9M) vs IRON (0).
IRONPHATIRON / PHAT
Capitalization1.58B227M698%
EBITDA-114.41M-272.12M42%
Gain YTD-26.893-59.23645%
P/E RatioN/AN/A-
Revenue081.9M-
Total Cash695M212M328%
Total Debt30.6M204M15%
TECHNICAL ANALYSIS
Technical Analysis
IRONPHAT
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGOAX56.61N/A
N/A
Hartford Growth Opportunities A
MREGX14.44N/A
N/A
BlackRock Unconstrained Equity R
PRPCX4.82N/A
N/A
PGIM Jennison Energy Infrastructure C
TCGLX51.03N/A
N/A
Touchstone Large Company Growth C
LHCFX17.98N/A
N/A
Lord Abbett Health Care F

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with KMSTF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then KMSTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
-0.56%
KMSTF - IRON
54%
Loosely correlated
N/A
ATBPF - IRON
53%
Loosely correlated
N/A
CGON - IRON
47%
Loosely correlated
-3.90%
ATXS - IRON
46%
Loosely correlated
-10.76%
IDYA - IRON
44%
Loosely correlated
-4.90%
More

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with TNFA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then TNFA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
+5.08%
TNFA - PHAT
39%
Loosely correlated
-8.83%
ATRA - PHAT
36%
Loosely correlated
+3.25%
IMTX - PHAT
35%
Loosely correlated
-4.82%
IRON - PHAT
34%
Loosely correlated
-0.56%
SYRE - PHAT
32%
Poorly correlated
-1.21%
More